' Misleading ' : No OS Benefit in NSCLC With Broad-Based Testing ' Misleading ' : No OS Benefit in NSCLC With Broad-Based Testing

A new study concludes that broad-based genetic testing does not improve survival for patients with advanced non-small cell lung cancer, but experts challenge this conclusion.Medscape Medical News
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news